Trial Details
COMPLETEDBasic Information
| Clinical ID | c1589 |
|---|---|
| Identifier | NCT00603733 |
| Trial Title | Canadian Active & Maintenance Modified Pentasa Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Active Ulcerative Colitis|Remission of Ulcerative Colitis |
| Interventions | DRUG: 5-ASA (5-Aminosalicylate)|DRUG: 5-ASA (5-Aminosalicylate) |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Calgary |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-07 |
|---|---|
| Primary Completion Date | 2025-05-11 |
| Completion Date | 2025-05-11 |